Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Serina Therapeutics (SER) Interest Income - Net (2024 - 2025)

Historic Interest Income - Net for Serina Therapeutics (SER) over the last 2 years, with Q2 2025 value amounting to $59000.0.

  • Serina Therapeutics' Interest Income - Net rose 12350.6% to $59000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$244000.0, marking a year-over-year change of. This contributed to the annual value of -$291000.0 for FY2024, which is 581.82% down from last year.
  • Per Serina Therapeutics' latest filing, its Interest Income - Net stood at $59000.0 for Q2 2025, which was up 12350.6% from $47000.0 recorded in Q1 2025.
  • Over the past 5 years, Serina Therapeutics' Interest Income - Net peaked at $59000.0 during Q2 2025, and registered a low of -$251000.0 during Q2 2024.